Observational studyThe Lancet. Infectious diseases2018

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.

Angela Huttner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.